MedTrace Logo

Surgical Resection for Hepatocellular Carcinoma

NCT06013657 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2023-08-28

No results posted yet for this study

Summary

Hepatocellular carcinoma is a type of liver cancer and is one of the leading causes of global cancer death. Surgical resection of the afflicted areas of the liver is one of the treatment methods for this condition. In this retrospective research, the investigators explore the outcomes of liver resection for hepatocellular carcinoma patients undergoing liver resection from 2010 to 2021 in Cipto Mangunkusumo General Hospital, Jakarta. The main outcome is mortality and the secondary outcomes are factors predicting mortality after resection.

Conditions

  • Resectable Hepatocellular Carcinoma

Interventions

PROCEDURE

Liver Resection

Resection of a part of the liver afflicted by hepatocellular carcinoma

Sponsors & Collaborators

  • Dr Cipto Mangunkusumo General Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-03-25
Completion
2022-06-01

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06013657 on ClinicalTrials.gov